The RBM39 gene helps cells edit RNA, the short working copy of DNA instructions, so they can make the right proteins at the right time. If this gene does not work well, cells may produce faulty protein messages, which can upset normal growth and survival. Because of this role, the RBM39 gene is being studied in cancer research, especially in blood cancers, but it is not a gene that is widely known outside medicine.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, which are the working parts of cells. Other genes mainly help control when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
RBM39Gene function
What if the gene works
The RBM39 gene helps cells edit RNA messages before making proteins. This supports normal gene activity, cell growth, and everyday cell function.
Risk
What if the gene does not work
Changes in the RBM39 gene can range from milder to more severe variants. They may partly or more strongly disrupt RNA splicing, the step that edits RNA messages, and alter control of many other genes.
Treatment
What does that mean for your treatment
No RBM39-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the RBM39 gene. In cancer research, the RBM39 gene is being studied as a drug target because some investigational medicines aim to lower RBM39 activity, but this is not part of routine care.
Gene function
What if the gene works
Inside your cells, the RBM39 gene helps turn fresh genetic messages into usable instructions. Its protein mainly works during RNA splicing, a step where extra pieces are removed before proteins are made. Understanding what the RBM39 gene does in the body helps explain how cells keep gene activity organized.
The RBM39 gene helps cells edit newly made RNA before it is used to build proteins. It works with the spliceosome (the cell’s RNA editing machinery) to remove extra segments and join the needed parts.
This gene also helps control which version of an RNA message is kept when one gene can be read in more than one way. That fine tuning supports normal protein production across many tissues.
RBM39 also supports the handoff between reading DNA and processing RNA, which keeps gene instructions moving in an orderly way. This coordination helps cells make usable messages more smoothly.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. Variants are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental factors. Many do not cause any noticeable effect and are simply part of natural genetic variation. At times, though, a variant changes gene function more significantly and can contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RBM39 gene can alter how the RBM39 protein folds, binds RNA, or works with the cell’s system for trimming and joining RNA, which helps explain how RBM39 gene variants affect protein function. Some changes are milder and only partly reduce activity, while more disruptive variants can shorten the protein, make it unstable, or cause a marked loss of function. This range can change how much RNA processing is disrupted inside cells.
How variants are linked to conditions
The RBM39 gene does not yet have a broadly confirmed link to a specific health condition, though research on RBM39 gene variants and disease risk is still developing. If you carry a reported variant in the RBM39 gene, your doctor or genetic counselor can interpret it in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RBM39 gene. Anyone concerned about personal or family risk can speak with a doctor or genetic counselor for advice based on their own medical history.
Inheritance of RBM39 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific RBM39-related condition. In practice, RBM39 gene inheritance is understood mainly at the chromosome level rather than as a clearly established dominant or recessive pattern. The RBM39 gene is located on chromosome 20, which is an autosome, so you inherit one copy of the gene from each parent.
What does my RBM39 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for RBM39, though this can become clearer as research grows. If you have a specific RBM39 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact result.
Genetic information
Genetic testing
How you find out about variants
RBM39 genetic testing looks for changes in the RBM39 gene by reading DNA from a blood or saliva sample, often as part of a multigene panel, exome sequencing, or genome sequencing. Results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have RBM39 genetic testing on its own. Testing decisions are usually based on your personal health history, family history, or results from broader testing, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it can tell you varies based on the condition and the type of variant involved. How the body functions over time is shaped by many factors, including age, lifestyle, the environment, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. One reason is that inherited differences can change how the body breaks down, transports, or responds to a drug. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the RBM39 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. Research on the RBM39 gene has mostly looked at how some experimental cancer treatments affect this protein inside tumor cells, rather than using inherited RBM39 results to guide routine prescribing.
History
RBM39 entered the scientific literature in the late 1990s, when researchers studying liver cancer described a related protein called HCC1. Soon after, other groups identified the same gene in work on how cells control gene activity and used names such as CAPERα, which added to early confusion around its identity. Over time, descriptions became more precise as scientists recognized that these findings pointed to the same RBM39 gene. Through the 2000s, research helped settle its place in human genetics and clarified the naming used in laboratories and medical papers. Today, RBM39 is mainly known within molecular and cancer research rather than through a single public event or landmark media story.